Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1164484614
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1300 Centerview Dr
Little Rock, AR, 72211
Phone (501) 508-7163
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
102,342 services
Medicare patients, 2024
1,018
Average age 74
Drug cost, 2024
$6.9M
4,724 prescriptions
Company payments, 2025
$4,407
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brad P Baltz was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 14,200 times for 27 patients. In total Brad P Baltz billed 102,342 services in 133 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 14,200 | 27 | $2.38 | $34K |
| J0896 Injection, luspatercept-aamt, 0.25 mg | Office | 11,500 | 11 | $31.86 | $366K |
| 36415 Venipuncture Blood Collection | Office | 4,592 | 912 | $8.61 | $40K |
| 85025 Blood Count | Office | 4,376 | 920 | $7.53 | $33K |
| 99213 Office E&M - Established | Office | 3,902 | 886 | $61.16 | $239K |
| 80053 Clinical Chemistry | Office | 3,739 | 880 | $10.29 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,881 | 663 | $11.81 | $22K |
| 83540 Clinical Chemistry | Office | 825 | 533 | $6.27 | $5,174 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 823 | 17 | $0.09 | $70.53 |
| 82728 Clinical Chemistry | Office | 820 | 529 | $13.21 | $11K |
| 82306 Clinical Chemistry | Office | 817 | 598 | $28.72 | $23K |
| 82607 Clinical Chemistry | Office | 799 | 584 | $14.65 | $12K |
| 99231 Hospital E&M - Subsequent | Facility | 767 | 142 | $35.06 | $27K |
| 84443 Clinical Chemistry | Office | 678 | 466 | $16.36 | $11K |
| 83550 Clinical Chemistry | Office | 665 | 499 | $8.46 | $5,628 |
By year: 2022 $632K for 32,185 services; 2023 $637K for 30,189 services; 2024 $2.2M for 102,342 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 4,592 | 912 | $8.61 | $40K |
| 85025 Blood Count | 4,376 | 920 | $7.53 | $33K |
| 80053 Clinical Chemistry | 3,739 | 880 | $10.29 | $38K |
| 83540 Clinical Chemistry | 825 | 533 | $6.27 | $5,174 |
| 82728 Clinical Chemistry | 820 | 529 | $13.21 | $11K |
| 82306 Clinical Chemistry | 817 | 598 | $28.72 | $23K |
| 82607 Clinical Chemistry | 799 | 584 | $14.65 | $12K |
| 84443 Clinical Chemistry | 678 | 466 | $16.36 | $11K |
| 83550 Clinical Chemistry | 665 | 499 | $8.46 | $5,628 |
| 82746 Clinical Chemistry | 663 | 561 | $14.29 | $9,473 |
Medicare prescription drug claims, 2024
In 2024, the drug Brad P Baltz prescribed most often to Medicare patients was Levothyroxine Sodium, with 363 prescriptions and refills. In total Brad P Baltz wrote 4,724 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 363 | 541 | 66 | $2,687 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 258 | 352 | 56 | $4,243 |
| Pantoprazole Sodium Generic | 240 | 413 | 52 | $1,751 |
| Eliquis Apixaban | 238 | 276 | 49 | $158K |
| Letrozole Generic | 230 | 418 | 43 | $3,345 |
| Tamoxifen Citrate Generic | 222 | 386 | 39 | $4,770 |
| Omeprazole Generic | 173 | 272 | 35 | $1,835 |
| Xarelto Rivaroxaban | 151 | 189 | 21 | $99K |
| Prednisone Generic | 147 | 197 | 37 | $816 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 145 | 203 | 30 | $1,042 |
| Ondansetron Hcl Generic | 131 | 135 | 44 | $1,116 |
| Jakafi Ruxolitinib Phosphate | 125 | 125 | 12 | $1.5M |
| Escitalopram Oxalate Generic | 114 | 162 | 19 | $854 |
| Potassium Chloride Generic | 98 | 166 | 19 | $1,842 |
| Promethazine Hcl Generic | 98 | 98 | 17 | $1,216 |
Brand drugs: 1,124 claims; generic drugs: 3,516 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brad P Baltz $4,407 ($4,407 in general payments such as food, travel and fees) from 46 companies. The largest payer was Pfizer Inc. with $312.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $312 |
| Incyte Corporation INCY | 11 | $293 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $276 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $256 |
| Celgene Corporation BMY | 16 | $211 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $205 |
| Merck Sharp & Dohme LLC MRK | 8 | $202 |
| Abbvie Inc. ABBV | 10 | $187 |
| BeOne Medicines USA, Inc. ONC | 8 | $174 |
| Daiichi Sankyo Inc. 4568.T | 7 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.